Studies involving placebo-controlled, double-blinded designs to evaluatethe effect of beta-glucan compositions on upper-respiratory tract infectionsand psychological wellness were carried out. During the course of the reportingperiods of these studies, subjects in the treatment groups reported fewer URTIsymptoms, better overall health and a more positive psychological assessmentbased on a POMS survey.
